Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nefopam and morphine in man.

A Sunshine, E Laska

    Clinical Pharmacology and Therapeutics
    |November 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Nefopam, a novel analgesic, demonstrated comparable efficacy to morphine for moderate to severe pain. This study found nefopam to be a safe and effective alternative analgesic with no observed adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An analgesic model for assessment of acute pain response in osteoarthritis of the knee.

    Osteoarthritis and cartilage·2006
    Same author

    A comparison of the newer COX-2 drugs and older nonnarcotic oral analgesics.

    The journal of pain·2003
    Same author

    Onset of analgesia for liquigel ibuprofen 400 mg, acetaminophen 1000 mg, ketoprofen 25 mg, and placebo in the treatment of postoperative dental pain.

    Journal of clinical pharmacology·2001
    Same author

    Recovery from psychotic illness: a 15- and 25-year international follow-up study.

    The British journal of psychiatry : the journal of mental science·2001
    Same author

    Onset and duration of analgesia for low-dose ketoprofen in the treatment of postoperative dental pain.

    Journal of clinical pharmacology·2001
    Same author

    Analgesic efficacy of liquid ketoprofen compared to liquid dipyrone and placebo administered orally as drops in postepisiotomy pain.

    International journal of clinical pharmacology and therapeutics·1999
    Same journal

    Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

    Clinical pharmacology and therapeutics·2026
    Same journal

    From Executor to Orchestrator: The Pharmacology Scientist in the Age of Agentic AI.

    Clinical pharmacology and therapeutics·2026
    Same journal

    The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Pain Management
    • Clinical Trials

    Background:

    • Nefopam is a novel analgesic agent.
    • It is chemically and pharmacologically distinct from existing analgesics.
    • Parenteral analgesia is required for moderate to severe pain.

    Purpose of the Study:

    • To compare the efficacy and safety of nefopam versus morphine.
    • To establish a dose-response relationship for nefopam.
    • To evaluate the time-effect profiles of both analgesics.

    Main Methods:

    • A double-blind, randomized study was conducted.
    • 74 patients with moderate to severe pain received either morphine or nefopam.
    • A single administration, 2-dose level design was employed.

    Related Experiment Videos

    Main Results:

    • Both nefopam and morphine showed significant dose-response curves.
    • Time-effect curves for both drugs were similar.
    • 20 mg of nefopam HCl was found to be equivalent to 12 mg of morphine sulfate in analgesic potency.

    Conclusions:

    • Nefopam exhibits comparable analgesic efficacy to morphine.
    • Nefopam demonstrated a favorable safety profile with no adverse effects observed.
    • Nefopam represents a potentially valuable alternative for parenteral analgesia.